Intermittent preventive treatment for malaria in infants: A decision-support tool for sub-Saharan Africa

Bulletin of the World Health Organization

Volumn 88, Issue 11, 2010, Pages 807-814

  Carneiro, Ilona ^a   Smith, Lucy ^a   Ross, Amanda ^b   Roca Feltrer, Arantxa ^a   Greenwood, Brian ^a   Schellenberg, Joanna Armstrong ^a   Smith, Thomas ^b   Schellenberg, David ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR;

ALGORITHM; CHILD HEALTH; DECISION SUPPORT SYSTEM; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TRANSMISSION; DISEASE TREATMENT; EPIDEMIOLOGY; MALARIA; POLICY MAKING;

AFRICA SOUTH OF THE SAHARA; AGE; ARTICLE; CHILD; DECISION SUPPORT SYSTEM; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; INFANT; INFANT MORTALITY; INTERNET; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; PLASMODIUM FALCIPARUM; PREDICTION; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL VARIATION; STOCHASTIC MODEL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; ALGORITHMS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DECISION SUPPORT TECHNIQUES; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH POLICY; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALE; MODELS, THEORETICAL; PLASMODIUM MALARIAE; STOCHASTIC PROCESSES; TIME FACTORS;

SUB-SAHARAN AFRICA;

PLASMODIUM FALCIPARUM;

EID: 78149231764     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.09.072397     Document Type: Article

References (50)

1. Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, Schellenberg JA et al. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 2010;5:e8988. doi:10.1371/journal.pone.0008988
2. Mulligan JA, Yukich J, Hanson K. Costs and effects of the Tanzanian national voucher scheme for insecticide-treated nets. Malar J 2008;7:32. doi:10.1186/1475-2875-7-32
3. Grabowsky M, Nobiya T, Selanikio J. Sustained high coverage of insecticide- treated bednets through combined Catch-up and Keep-up strategies. Trop Med Int Health 2007;12:815-22. doi:10.1111/j.1365-3156.2007.01862.x
4. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001;357:1471-7. doi:10.1016/S0140-6736(00)04643-2
5. Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ 2005;331:727-33. doi:10.1136/bmj.331.7519.727
6. Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis 2006;194:276-85. doi:10.1086/505431
7. Grobusch MP, Lell B, Schwarz NG, Gabor J, Dornemann J, Potschke M et al. Intermittent preventive treatment against malaria in infants in Gabon-a randomized, double-blind, placebo-controlled trial. J Infect Dis 2007;196:1595-602. doi:10.1086/522160
8. Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007;45:16-25. doi:10.1086/518575
9. Mockenhaupt FP, Reither K, Zanger P, Roepcke F, Danquah I, Saad E et al. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana. Antimicrob Agents Chemother 2007;51:3273-81. doi:10.1128/AAC.00513-07
10. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 2009;374:1521-32. doi:10.1016/S0140-6736(09)60997-1
11. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 2009;374:1533-42. doi:10.1016/S0140-6736(09)61258-7
12. Report of the technical consultation on intermittent preventive treatment in infants (IPTi), Technical Expert Group on Preventive Chemotherapy. Geneva: World Health Organization; 2009. Available from: http://malaria.who.int/docs/ IPTi/TEGConsultIPTiApr2009Report.pdf [accessed 23 September 2009].
13. O'Meara WP, Breman JG, McKenzie FE. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J 2005;4:33. doi:10.1186/1475-2875-4-33
14. Greenwood B. Review: Intermittent preventive treatment-a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health 2006;11:983-91. doi:10.1111/j.1365-3156.2006.01657.x
15. Chandramohan D, Webster J, Smith L, Awine T, Owusu-Agyei S, Carneiro I. Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? Trop Med Int Health 2007;12:743-50. doi:10.1111/j.1365-3156.2007.01844.x
16. Roca-Feltrer A, Schellenberg JR, Smith L, Carneiro I. A simple method for defining malaria seasonality. Malar J 2009;8:276. doi:10.1186/1475-2875-8-276
17. Cairns M, Carneiro I, Milligan P, Owusu-Agyei S, Awine T, Gosling R et al. Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. PLoS One 2008;3:e2227. doi:10.1371/journal.pone.0002227
18. May J, Adjei S, Busch W, Gabor JJ, Issifou S, Kobbe R et al. Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon. Malar J 2008;7:198.
19. Smith T, Killeen GF, Maire N, Ross A, Molineaux L, Tediosi F et al. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. Am J Trop Med Hyg 2006;75(Suppl):1-10.
20. Hastings IM, Watkins WM. Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol 2006;22:71-7. doi:10.1016/j. pt.2005.12.011
21. Ross A, Penny M, Maire N, Studer A, Carneiro I, Schellenberg D et al. Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants. PLoS One 2008;3:e2661. doi:10.1371/journal. pone.0002661
22. WHO immunization surveillance, assessment and monitoring: immunization schedule. Geneva: World Health Organization; 2007. Available from: www. who.int/immunization_monitoring/data/data_subject. [accessed 5 August 2009].
23. Maire N, Aponte JJ, Ross A, Thompson R, Alonso P, Utzinger J et al. Modeling a field trial of the RTS,S/AS02A malaria vaccine. Am J Trop Med Hyg 2006;75(Suppl):104-10.
24. Goodman CA, Coleman PG, Mills A. Economic analysis of malaria control in sub-Saharan Africa. Geneva: Global Forum for Health Research; 2000.
25. Measure DHS. Demographic and Health Surveys. Calverton: Measure DHS; 2007. Available from: http://www.measuredhs.com/ [accessed 10 June 2009].
26. United Nations Children's Fund. Multiple indicator cluster surveys. New York: UNICEF; 2009. Available from: http://www.childinfo.org/mics.html [accessed 10 June 2009].
27. World Health Organization, United Nations Children's Fund. WHO-UNICEF time series estimates of DTP3 coverage. Geneva: WHO, UNICEF; 2009. Available from: http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tswucoveragedtp3.htm [accessed 4 May 2010].
28. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008;372:1545-54. doi:10.1016/S0140-6736(08)61654-2
29. Schellenberg D, Menendez C, Aponte J, Guinovart C, Mshinda H, Tanner M et al. The changing epidemiology of malaria in Ifakara Town, southern Tanzania. Trop Med Int Health 2004;9:68-76. doi:10.1046/j.1365-3156.2003.01161.x
30. Trape J-F, Rogier C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 1996;12:236-40. doi:10.1016/0169-4758(96)10015-6
31. Marsh K, Snow RW. Malaria transmission and morbidity. Parassitologia 1999;41:241-6.
32. Ross A, Maire N, Molineaux L, Smith T. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. Am J Trop Med Hyg 2006;75(Suppl):63-73.
33. Smith T, Ross A, Maire N, Rogier C, Trape JF, Molineaux L. An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg 2006;75(Suppl):56-62.
34. Beier JC, Killeen GF, Githure JI. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med Hyg 1999;61:109-13.
35. Hay SI, Rogers DJ, Toomer JF, Snow RW. Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg 2000;94:113-27. doi:10.1016/S0035-9203(00)90246-3
36. Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM et al. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 2009;6:e1000048. doi:10.1371/journal.pmed.1000048
37. Gething PW, Patil AP, Hay SI. Quantifying aggregated uncertainty in Plasmodium falciparum malaria prevalence and populations at risk via efficient space-time geostatistical joint simulation. PLoS Comput Biol 2010;6:e1000724. doi:10.1371/journal.pcbi.1000724
38. Menon A, Snow RW, Byass P, Greenwood BM, Hayes RJ, N'Jie AB. Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers. Trans R Soc Trop Med Hyg 1990;84:768-72. doi:10.1016/0035-9203(90)90071-L
39. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P, Hayes RJ et al. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet 1988;1:1121-7. doi:10.1016/ S0140-6736(88)91949-6
40. Greenwood BM, Greenwood AM, Smith AW, Menon A, Bradley AK, Snow RW et al. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children. Trans R Soc Trop Med Hyg 1989;83:182-8. doi:10.1016/0035-9203(89)90635-4
41. Alonso PL, Lindsay SW, Armstrong Schellenberg JR, Keita K, Gomez P, Shenton FC et al. A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria. Trans R Soc Trop Med Hyg 1993;87(Suppl 2):37-44. doi:10.1016/0035-9203(93)90174-O
42. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font F et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997;350:844-50. doi:10.1016/S0140-6736(97)04229-3
43. Sazawal S, Black RE. Meta-analysis of intervention trials on case- management of pneumonia in community settings. Lancet 1992;340:528-33. doi:10.1016/0140-6736(92)91720-S
44. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2004. 2CD000363.
45. Cissé B, Sokhna C, Boulanger D, Milet J, Bâ H, Richardson K et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxinepyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 2006;367:659-67. doi:10.1016/S0140-6736(06)68264-0
46. Sokhna C, Cissé B, Bâ H, Milligan P, Hallett R, Sutherland C et al. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 2008;3:e1471. doi:10.1371/journal.pone.0001471
47. Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, Kone M et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J 2008;7:123. doi:10.1186/1475-2875-7-123
48. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B et al. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One 2008;3:e4000. doi:10.1371/journal.pone.0004000
49. Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull World Health Organ 2009;87:123-9. doi:10.2471/BLT.08.051961
50. Roll Back Malaria Partnership. Global malaria action plan for a malaria-free world 2008. Geneva: RBM Partnership; 2008.